New Key Statistics Module, Z-Score and F-Score
NAS:VIR Key Ratios
| Market Cap $ M | 1,118.00 |
| Enterprise Value $ M | -361.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.70 |
| Price/Sales | 25.81 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 39.00 |
| EPS (TTM) $ | -4.59 |
| Beneish M-Score | -9.64 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -179.60 |
| EV-to-EBIT | 0.53 |
| EV-to-EBITDA | 0.54 |
| PEG | -- |
| Shares Outstanding M | 135.84 |
| Net Margin (%) | -1,557.35 |
| Operating Margin % | -1,732.68 |
| Pre-tax Margin (%) | -1,590.61 |
| Quick Ratio | 9.05 |
| Current Ratio | 9.05 |
| ROA % (ttm) | -26.34 |
| ROE % (ttm) | -33.70 |
| ROIC % (ttm) | -200.09 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.54 |
VIR Number of Guru Trades
VIR Volume of Guru Trades
Gurus Latest Trades with NAS:VIR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VIR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vir Biotechnology Inc Insider Transactions
No Available Data
News about NAS:VIR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers